Rocket


News + Filings
Transactions



Anish Bhatnagar

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/26/2023SOLENO THERAPEUTICS INCSLNOGrantCommon Stock160.6k$0.00$0 05/26/2023
05/26/2023SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)481.8k$5.25$2.5M 05/26/2023
05/08/2023SOLENO THERAPEUTICS INCSLNOGrantWarrants (right to buy)3.5k$2.50$8.8k 05/08/2023
05/08/2023SOLENO THERAPEUTICS INCSLNOGrantWarrants (right to buy)2.1k$1.75$3.8k 05/08/2023
01/25/2023SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)115k$2.41$277.2k 01/25/2023
07/27/2022SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)1.1M$0.17$190.3k 07/27/2022
03/31/2022SOLENO THERAPEUTICS INCSLNOPurchaseWarrant (right to buy)60k$0.30$18k 03/31/2022
03/31/2022SOLENO THERAPEUTICS INCSLNOPurchaseCommon Stock60k$0.00$0 03/31/2022
01/28/2022SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)610k$0.34$207.4k 01/28/2022
01/21/2022SOLENO THERAPEUTICS INCSLNOSaleCommon Stock39k$0.37$14.6k 01/21/2022
01/23/2021SOLENO THERAPEUTICS INCSLNOPayment of ExerciseCommon Stock36.3k$2.11$76.6k 01/23/2021
01/23/2021SOLENO THERAPEUTICS INCSLNOPayment of ExerciseCommon Stock36.3k$2.11$76.6k 01/23/2021
01/08/2021SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)2.1M$2.24$4.7M 01/08/2021
05/18/2020SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)350k$3.41$1.2M 05/18/2020
01/23/2020SOLENO THERAPEUTICS INCSLNOGrantCommon Stock381k$3.35$1.3M 01/23/2020
01/24/2019SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)250k$1.67$417.5k 01/24/2019
02/07/2018SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)400k$1.60$640k 02/07/2018
02/07/2018SOLENO THERAPEUTICS INCSLNOGrantRestricted Stock Units100.6k$0.00$0 02/07/2018
04/19/2017SOLENO THERAPEUTICS INCSLNOGrantEmployee stock option (right to buy)1.7M$0.59$993.5k 04/19/2017
05/13/2016SOLENO THERAPEUTICS INCSLNOPurchaseCommon Stock5k$1.15$5.7k 05/13/2016

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy